MTA1 and prostate cancer: Importantly, in a recent paper using genetically modified DU145 and PC3M prostate cancer cells, gnetin C was shown to have more potent MTA1-mediated cytotoxicity, apoptosis, inhibition of clonogenic cell survival, and motility compared to resveratrol and pterostilbene [31].